Electromagnetic interference between external defibrillator and cardiac resynchronization therapy-pacemaker (CRT-P) devices.
نویسندگان
چکیده
BACKGROUND Implantable heart rhythm devices are susceptible to interference in hospitals where electromagnetic interference (EMI) sources are ubiquitous. CASE DESCRIPTION We report three cases in which EMI from the external defibrillator caused the inability to interrogate Boston Scientific cardiac resynchronization therapy-pacemaker (CRT-P) devices. We have documented interference with the Boston Scientific CRT-P Contact Renewal device model numbers H120/H125 (Natick, MA, USA) and two brands of external defibrillators: the Philips Heartstart XL model number M4735A (Andover, MA, USA) and the Hewlett-Packard Codemaster model number M1722B (Palo Alto, CA, USA). For device implants, we routinely place external pacing pads with the external defibrillator in the "standby" mode for transcutaneous pacing so that only the pacer "start/stop" button needs to be pressed when necessary. We have not been able to interrogate three consecutive Boston Scientific CRT-P devices prior to closure while the external defibrillator had the back-up pacing mode on "standby." In our initial case, a second device was opened because this interaction was not recognized. We documented EMI with the standby pacing mode ON and discovered that by disabling only the "standby" pacing mode on the external defibrillator, the device could be interrogated without difficulty. CONCLUSIONS This is a case series reporting EMI with a Boston Scientific CRT-P Contact Renewal device H120/H125 telemetry from an external defibrillator with pacing mode on "standby." Failure to recognize this important interaction may lead to inappropriate device and resource utilization.
منابع مشابه
Effects of Upgrade Versus De Novo Cardiac Resynchronization Therapy on Clinical Response and Long-Term Survival
The beneficial impact of newly implanted cardiac resynchronization therapy (CRT) on morbidity and mortality are well described in selected patients with heart failure. Patients with heart failure already fitted with a conventional pacemaker or implantable cardioverter defibrillator (ICD) system are often considered for a CRT upgrade after the new development of CRT criteria (ie, new left bundle...
متن کاملMyocardial scar sizing and characterization predicts ventricular arrhythmia in cardiac resynchronization therapy candidates
Background There is not enough evidence to support the use of combined Implantable Cardiac Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT) devices in all CRT candidates. Stronger predictors of malignant ventricular arrhythmia (VA) and sudden cardiac death (SCD) are required. The purpose of this study was to assess the value of myocardial scar extension and scar characterization...
متن کاملLead extraction: The road to successful cardiac resynchronization therapy.
BACKGROUND Still increasing life expectancy in patients with implanted devices and large number of leads more and more often induce the need to cure the treatment complications or to change especially to cardiac resynchronization therapy (CRT). In order to prevent further complications, the possibility of damaged or redundant leads extraction should be taken into consideration. The aim of the p...
متن کاملArrhythmia/Electrophysiology Long-Term Outcome After ICD and CRT Implantation and Influence of Remote Device Follow-Up The ALTITUDE Survival Study
Background—Outcome data for patients receiving implantable cardioverter-defibrillator (ICD) and cardiac resynchronization therapy– defibrillator (CRT-D) devices treated outside of clinical trials are lacking. No clinical trial has evaluated mortality after device implantation or after shock therapy in large numbers of patients with implanted devices that regularly transmit device data over a ne...
متن کاملInhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device
Advanced heart failure is the most frequent diagnosis in adult patients admitted to the hospital. The prevalence of heart failure has increased as options for treatment have improved. In addition to pharmacologic therapies, standard implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-D) have decreased mortality and improved quality of life. L...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Pacing and clinical electrophysiology : PACE
دوره 34 9 شماره
صفحات -
تاریخ انتشار 2011